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- 
ber and account for 14 kilobases or -0.6% of the gene, 
whereas the residual part co spends to intervening n3n- 
ystrsphin gene mutations, 
letions, lead to the severe 
nme rn~s~~lar dystrophy or 
the relatively milder Becker muscular dystrophy. 
an out-of-frame r ading in the sequence downstream of the 
deletion would produce astop codon, out-of-frame d letions 
will lead to Buchenne muscular dystrophy, whereas in-frame 
deletions will produce aBecker muscular dystrophy pheno- 
type. In this case, part of the coding sequence is removed, 
but the correct reading downstream of the deletion is pre- 
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years old (15 patients), Group B, I6 to 30 years old 06 
o735-tWf9831%. 
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patients) and group C, >30 years ofage (5 patients). In 18 
p&ems, including two brothers and four uncle-nephew 
pain, there was a positive family history. The diagnosis was 
estabhshed byneurologic examination a d muscle biopsy. 
Clinical severity wirs scored according toHoffman et al. (22): 
ntild = high serum creatine kinase levels or muscle hypere 
tmhy, or bosh, with easy fatigability ; noA~~~re = as in mild 
severity, with some difficulty in climbing stairs, obvious 
chnical weakness and waddling ait; sev~e = as for mild and 
m&et&e severity, with significant loss of strength, marked 
scanner with a circuit for tiythmis 
and d&a reduction hfinder model 3). During 
lents followed their normal 
ddly routine and kept a diary of symptoms and activity 
kvels. Ventricular rrhythmias were classified according to 
the: Lswn settle. 
Dystrqhin analyses were per- 
Ad knmunohistsehemical assays on 
k’Mns Obtained from 24 patients after 
ent wits obtained. Western blot was 
1~ to Hoffman et al. (22) using either a 
nat he mid-rod omain (30 kd) or a 
monoclonal ntibody against the C-terminal of the protein. 
Immunohistochemical assay was performed using, three dif- 
ferent monoclonal ntibodies (NQVQC~ 
the N-terminal (amino acids 321 to 
(amino acids 3,669 to 3,685) and the mr 
acids 1,181 to 1,38@ of the dy~tr~~b~~ ~ cc~~c~ 
susly described (24). Three independent observers, 
recorded l abnormalities, scored all of the sections ina 
blinded manner for negative fibers (
absence of~~ct~~~ aEong the entin 
lere 
ent. Onset of clinical symptoms 
in the patients usuaby occurred in the t 
Gmup A (IS patients), clinical severity wa 
nd severe in3 (27%). Two patients had 
up C (five patients), dis- 
), moderate in one (20%) 
Respiratory performance was 
% to 82%) in four, moderate (range 52% to 62%) in
vere (<52%) in two. 
~vo~ve~e~t. Only o e patient (Patient 30) was 
symptomatic, manifesting syncape and exertional dyspnea. 
Six months after examination, this patient died suddenly. 
Although most patients were apparently asymptomatic, 
only 10 patients (32%) had a normal ECG (Table 2). Incom- 
plete right bundle branch block was observed in six patients. 
Moreover, complete right bundle branch bleak, incomplete 
left bnzdle branch block, complete left bundle branch block 
16 16 Del 45-49 NA 390 50 ild 
17 17 Not del ttt 100 IO + 
18 13 Not del tt 390 40 Mild (TM) 4 
19 20 Del 48 370 IO0 Mild + 
20 20 Del 45-47 -I- 360 40 Mild t 
21 23 Not de1 400 30 Mild + 
22 34 Dei 3-4 NA NA NA Severe t 
23 ?I Not Del ++I” 3w 100 !hWt? 
24 28 Del 45-47 ?lA NA NA Moderate 
25 30 Del 45-48 t 370 40 Moderate + 
26 30 Noi del NA NA NA Severe 
Group C (>3O years old) 
_-.__- 
27 32 Not dcl 3#0 20 Mild + 
28 33 Dl!l45-47 f 380 40 ModelMc + 
29 35 Del 3-4 NA NA NA Severe + 
30 36 Del 4.5-48 380 IMJ Mild + 
31 50 Del 4.5-49 NA MA NA Severe + 
._ _-eIp 
‘Dystropi 111 negative fibers: I- = a smlrll number; tf = many; c t + = 8 large number: - = RO negative fibers, but generalized hyporeaction. Wormal 
dywophin sil I! = 100 kd. Del = deletion; Dupl = duplication: M = myoglobinuria; NA = not available. Not del = no detectable deletions; PI = patient. 
and left posterior fascicular block were observed singly in 
four patients. 
In one patient, Q waves were seen in the lateral and 
inferior leads. Another patient had reduced R wave voltage 
in the anterior leads. Five patients had abnormally tall K 
waves in lead \I, (R/S > 1). Two patients had aspecific SY 
segment changes in the peripheral leads and two had neg? - 
tive T waves in right precordial leads (V,, V, and Y3). Th:: 
symptomatic patient had complete l ft bundle branch block 4 
Electrophysiologic studies documented the presence of iii I 
infra-hisian block (L-IV interval 80 ms), and a pacemaker wai 
implanted. This patient also had polymorphic ventricular 
arrhythmias (Lown grade 3) but refused antiarrhythmis 
treatment. Life-threatening ventricular arrhythmias (Lawn 
grade 4a and 4b) were also documented in two other patients 
with severe restrictive r spiratory insuficiency (forced vital 
d 26%, respectively), Isolated monomo~hic 
ature beats were recorded in I patient 
de 2) and in I1 patients (~3 
grade 1). 
Echocardiognphic f ndings were normal in 12 patients 
(38%), and demonstrated dimensional, s 
right ventricular involvement alone or in 
patients (52% of the totaal) ( 
Left v~r~t~icular di tion 
(22%). Ejection fraction was red 
Left ventricular wall motion ab 
six patients (Table 2). These cardiologic indents eemed to 
be unrelated to he extent and severity of skeletal ~~sc~~ 
involvement, with the exception of the respiratory muscles 
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3 NT T wave changes N 37 55 61 N 63 N 
4 69 (ml IUSPf N 38 50 62 N 
s NT WS>l Lawn I N 63 69 N 
6 107 (NI N Lownl N 51 66 N 
R/s > 1 N N 50 6l N Id 
WS 3 I N 25 36 57 54 BA 
NW08i8 &awn I 43 74 49 AH 59 A 
N 
SA 
AH 
N 
58 N 
22 92 (NJ 
23 92 (N) 
24 NT 
25 NT 
26 37 (9 
910’0 
NT 
NT 
109 0’0 
NT 
N 
DH 
N 
Lawn 1 
NT 
N 
Lowa I 
Lawn 4a 
N 
N 
N 
29 
N 
SO 
77 
69 
78 
as NT Necrosis NT 36 59 46 PLH 63 53 
N Lowill 29 44 55 N 52 52 
75 ItR) N 61 N N N 
39 69 65 SA 
1 74 ss N N N 
< FVC crate (M) and FVC < SE% = severe 
anterior a; BA = band abnormalities; DW = 
BBB (itEBB) = complete (incomplete) left bundle bmnch 
LVBE = Seat ventricular ejecliow fraction; NT = not rested; 
complete (incomplete) &ht bundle branch block: RVEDV = right ventricular end-diastolic 
f-rmhl was signilicantiy reduced 
control values and values inGroup 
m for the left ventricle were ob- 
in Group C patients. Linear egression a -!ysis to 
evaluate he comeliation between patient age and left ventric- 
ular volume or ejection faction gave coefficients of r = 0.38 
and -0.36, respectively (p < MB), 
Figure 2 demibes the dystrophin gene 
with its exo&t&n structure a>:ld shows the sites of the most 
firmest deletions involved in Becker muscular dystrophy/ 
Duchenne muscular dystrophy. An iatragenic n-frame dele- 
tion was present in 19 (61%) of 31 patients. No detectable 
detetions were found in 10 patients (320/o), and duplications 
spanning exons 13 to 42 and 45 to 48 were observed in 2 
patients, respectively. No cardiac abnormality was observed 
nt showed at-i int 
deletion that included ex3ms 48 and 49. 
findings were normal in atients 10 and 19, with deletion of 
the single exon 48, and ey were normal or borderline in
5 45 to 47. 
s. Figure 3 describes the dystrophin 
rent domains and the antibodies u ed in 
this study, as well as an example o~dystr~~~~~ 
Immunofluorescence studies were performe 
ens from 23 patients; 14 of the 23 showed a variable 
number of dystrophin-negative f b rs and nine a mild or 
marked generalized hyporeaction without negative fibers. 
The amount ofdystrophin as determined on the Western blot 
was highly reduced (GO% of control values) in 15 (65%) of 
23 patients and moderately reducers 
CQ~I~POI values) in 8 (35%) of 23 patients. 
dystro~h~~ expression was identified in human 
rectly linked to the expression f an altered dy~tro~bi~~ 
Table 3. Echocardiographic Values in Patients With Becker Musclnlar Dystrophy and 
Control Subjects 
-- 
Patient Groups 
C0fltr0l 
Group A Group B Group C §ubjects 
(n = 15) la = 11) (n = 5) la = 38) 
-pE_Y_C_____.e 
WVEDV (ml/m*) 64.2 1 1s.s* 65.5 L 14.8? 61.3 2 W.6$ 48 z 6 
RVEF (98 59.9 2 6.8 59.3 k, Il.5 56.7 1 7.2 6025 
LVEDV lmllm*) 56.5 ?I 13.1 65.5 L 15.6 64.8 + 15.5 6426 
95% 
Confidence 
Limits 
38 to 5s 
52 to 68 
55 to 73 
LVEF&) 59.3 2 6.4#” 50.8 ‘- 9.9n 51.2 ;t 8.7# SW 2 3 53 to 63 
m --_P_ 
*p < 0.05 by Student-Newman-Keuls test (Group A vs. control subjects; @roup B vs. conlrol subjects; SGrceup 
C vs. control subjects: PGroup A vs. Group B; l]Group A vs. Group C; BGroup B vs. control subjecls: W Group C 
vs. control subjects). Values presented are mean value + SD. 
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ena with its cxonl 
r common i patients with Duchenne 
ns in only orto patient, he tall R 
the ventricles Qechocardiography showed that the right 
ventricular involvement seems to occur in the 
of the disease as an isolated phenomenon r
let ventricular systolic function in Becker muscular dystro- 
phy, we observed a significant reduction i  left ventricular 
ejection fraction with or without dilation of the same ventri- 
cle 
yt~~~~s, The detection of severe ar- 
rhythmias may provide useful informative on the natural 
history of cardiac disease in patients with 
dystrophy. The only patient in aur series who died suddenly 
had important polymorphic ventricular rhythmias, asdoc- 
umented by Holter monitoring. Life-threatening arrhythmias 
were detected in three additional patients with left ventric- 
ular dysfunction associated with severe restrictive respira- 
tory insufficiency and left ventricular conduction distur* 
bances. 
the dy§trOphill ~iilteratiOtl, 
w might have been expected between in- 
fibers in skeletal muscle or dystrophin size or 
severity of the myopathy w 
situation might be due t heterogeneity of the dystrophin 
gene m~tati~~s~ which Eerent portions of the mole- 
cule, and thus could different effect on cardiac 
function. Pohtano et al. (20) noted that cardiac involvement 
in patients with Becker and D.tchenne muscular dystrophy 
might be associated with specific intrqenic deletions involv- 
ing exon 49. In a serie:; of 19 patients with Becker muscular 
dystrophy showing inrragenic deletions in the region e corn- 
passing exons 47 to 52, al1 of the exon 49 deletions were 
associated with cardiatnyopathy. Deletions including exons 
47 and 48 were mostly (four of six) associated with cardio- 
rclyopathy, whereas a s of exon 47 was not 
associated with cardiac i vement. Steare t al. (19) found 
no correhttion between cardiac involvement and specific 
intragenic deletions in a series of 12 patients with Becker 
muscular dystrophy, 7of whom showed ifferent deletions 
in the region including exons 45 to 49. In our series, the 
deletion of exons 45 to 47 seemed to have no effect on the 
heart. Deletion of exon 49 was invariably associated with 
cardiac involvement, whereas deletion of exon 48 was 
sentation of dystrophin messenger r~b~~~~~e~~ 
the corresponding p
s: N-terminal domain 
recognized by antibodies used in the p 
Dystrophin Western blot showing normal dystrophin In corrtrol 
sibjects (400 &Is) and reduced molecular weight prote’ * 
with Becker muscular dystrophy (380 kB) (lane 3). 
terminal; NH2 = amjnoterm~~~a~; I 2 3 4 5 = lanes; 18 
exmss numbers. 
the single xon 48 was 
On the basis of these 
one could presume that myocardia~ 
tissue deserves consideration be 
exonic sequences in ~r~d~ci~g a 
dystro~bi~ gene is clearly d~c~memted~ 
We acknowledge A. Vianelto, MD for respiratory evaluation and E. P. 
Hoffman. PhD and L. Vergani, BS for dystrophin Western blots. 
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